Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-01-18 @ 1:45 PM
Study NCT ID:
NCT02567656
Status:
COMPLETED
Last Update Posted:
2020-01-13
First Post:
2015-09-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma
Sponsor:
Rhizen Pharmaceuticals SA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2018-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-03
First Submit QC Date:
None
Study First Post Date:
2015-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-06
Results First Submit QC Date:
None
Results First Post Date:
2020-01-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-23
Last Update Post Date:
2020-01-13
Last Update Post Date Type:
ACTUAL